{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:52:12Z","timestamp":1794631932050,"version":"4.9.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Struct Mol Biol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1038\/s41594-023-01123-3","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T16:02:39Z","timestamp":1697472159000},"page":"1794-1805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["The substrate and inhibitor binding mechanism of polyspecific transporter OAT1 revealed by high-resolution cryo-EM"],"prefix":"10.1038","volume":"30","author":[{"given":"Tongyi","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4928-6260","authenticated-orcid":false,"given":"Tengfei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1692-7906","authenticated-orcid":false,"given":"Jiansen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"1123_CR1","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1074\/jbc.272.10.6471","volume":"272","author":"CE Lopez-Nieto","year":"1997","unstructured":"Lopez-Nieto, C. E. et al. Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J. Biol. Chem. 272, 6471\u20136478 (1997).","journal-title":"J. Biol. Chem."},{"key":"1123_CR2","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1242\/jcs.107.4.1065","volume":"107","author":"GD Simonson","year":"1994","unstructured":"Simonson, G. D., Vincent, A. C., Roberg, K. J., Huang, Y. & Iwanij, V. Molecular cloning and characterization of a novel liver-specific transport protein. J. Cell Sci. 107, 1065\u20131072 (1994).","journal-title":"J. Cell Sci."},{"key":"1123_CR3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0014-5793(97)01325-2","volume":"417","author":"K Mori","year":"1997","unstructured":"Mori, K. et al. Kidney-specific expression of a novel mouse organic cation transporter-like protein. FEBS Lett. 417, 371\u2013374 (1997).","journal-title":"FEBS Lett."},{"key":"1123_CR4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/geno.1998.5722","volume":"56","author":"KP Brady","year":"1999","unstructured":"Brady, K. P. et al. A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse. Genomics 56, 254\u2013261 (1999).","journal-title":"Genomics"},{"key":"1123_CR5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","volume":"20","author":"M Nishimura","year":"2005","unstructured":"Nishimura, M. & Naito, S. Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab. Pharmacokinet. 20, 452\u2013477 (2005).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"1123_CR6","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","volume":"35","author":"C Hilgendorf","year":"2007","unstructured":"Hilgendorf, C. et al. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab. Dispos. 35, 1333\u20131340 (2007).","journal-title":"Drug Metab. Dispos."},{"key":"1123_CR7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","volume":"24","author":"AN Rizwan","year":"2007","unstructured":"Rizwan, A. N. & Burckhardt, G. Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm. Res. 24, 450\u2013470 (2007).","journal-title":"Pharm. Res."},{"key":"1123_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","volume":"95","author":"SK Nigam","year":"2015","unstructured":"Nigam, S. K. et al. The organic anion transporter (OAT) family: a systems biology perspective. Physiol. Rev. 95, 83\u2013123 (2015).","journal-title":"Physiol. Rev."},{"key":"1123_CR9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1146\/annurev-pharmtox-010617-052713","volume":"58","author":"SK Nigam","year":"2018","unstructured":"Nigam, S. K. The SLC22 transporter family: a paradigm for the impact of drug transporters on metabolic pathways, signaling, and disease. Annu. Rev. Pharmacol. Toxicol. 58, 663\u2013687 (2018).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1123_CR10","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/toxins2082055","volume":"2","author":"Y Hagos","year":"2010","unstructured":"Hagos, Y. & Wolff, N. A. Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity. Toxins (Basel) 2, 2055\u20132082 (2010).","journal-title":"Toxins (Basel)"},{"key":"1123_CR11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2133\/dmpk.DMPK-13-NT-070","volume":"29","author":"M Sakiyama","year":"2014","unstructured":"Sakiyama, M. et al. A common variant of organic anion transporter 4 (OAT4\/SLC22A11) gene is associated with renal underexcretion type gout. Drug Metab. Pharmacokinet. 29, 208\u2013210 (2014).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"1123_CR12","first-page":"1193","volume":"50","author":"SW Yee","year":"2021","unstructured":"Yee, S. W. & Giacomini, K. M. Emerging roles of the human solute carrier 22 family. Drug Metab. Dispos. 50, 1193\u20131210 (2021).","journal-title":"Drug Metab. Dispos."},{"key":"1123_CR13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0003-2697(74)90161-4","volume":"60","author":"PN Chow","year":"1974","unstructured":"Chow, P. N. An improved toluene-triton-based liquid scintillation system for counting 14C-labeled compounds at ambient temperature. Anal. Biochem. 60, 322\u2013328 (1974).","journal-title":"Anal. Biochem."},{"key":"1123_CR14","first-page":"1039","volume":"283","author":"S Masuda","year":"1997","unstructured":"Masuda, S., Saito, H. & Inui, K. I. Interactions of nonsteroidal anti-inflammatory drugs with rat renal organic anion transporter, OAT-K1. J. Pharmacol. Exp. Ther. 283, 1039\u20131042 (1997).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1123_CR15","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1074\/jbc.275.6.4507","volume":"275","author":"SH Cha","year":"2000","unstructured":"Cha, S. H. et al. Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J. Biol. Chem. 275, 4507\u20134512 (2000).","journal-title":"J. Biol. Chem."},{"key":"1123_CR16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/jpet.301.1.293","volume":"301","author":"H Kimura","year":"2002","unstructured":"Kimura, H. et al. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J. Pharmacol. Exp. Ther. 301, 293\u2013298 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1123_CR17","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.102.034330","volume":"302","author":"M Takeda","year":"2002","unstructured":"Takeda, M. et al. Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J. Pharmacol. Exp. Ther. 302, 666\u2013671 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1123_CR18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/cpt.1224","volume":"104","author":"KM Giacomini","year":"2018","unstructured":"Giacomini, K. M., Galetin, A. & Huang, S. M. The International Transporter Consortium: summarizing advances in the role of transporters in drug development. Clin. Pharmacol. Ther. 104, 766\u2013771 (2018).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1123_CR19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/clpt.2013.74","volume":"94","author":"KM Hillgren","year":"2013","unstructured":"Hillgren, K. M. et al. Emerging transporters of clinical importance: an update from the International Transporter Consortium. Clin. Pharmacol. Ther. 94, 52\u201363 (2013).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1123_CR20","unstructured":"FDA. In Vitro Drug Interaction Studies \u2014 Cytochrome P450 Enzyme and Transporter-Mediated Drug Interactions Guidance for Industry (2020)."},{"key":"1123_CR21","unstructured":"FDA. Clinical Drug Interaction Studies \u2014 Cytochrome P450 Enzyme and Transporter-mediated Drug Interactions Guidance for Industry (2020)."},{"key":"1123_CR22","unstructured":"EMA. Guideline on the Investigation of Drug Interactions (2012)."},{"key":"1123_CR23","first-page":"F122","volume":"276","author":"M Hosoyamada","year":"1999","unstructured":"Hosoyamada, M., Sekine, T., Kanai, Y. & Endou, H. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am. J. Physiol. 276, F122\u2013F128 (1999).","journal-title":"Am. J. Physiol."},{"key":"1123_CR24","first-page":"672","volume":"290","author":"S Jariyawat","year":"1999","unstructured":"Jariyawat, S. et al. The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. J. Pharmacol. Exp. Ther. 290, 672\u2013677 (1999).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1123_CR25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2014.04.004","volume":"59","author":"K Maeda","year":"2014","unstructured":"Maeda, K. et al. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans. Eur. J. Pharm. Sci. 59, 94\u2013103 (2014).","journal-title":"Eur. J. Pharm. Sci."},{"key":"1123_CR26","doi-asserted-by":"crossref","first-page":"F503","DOI":"10.1152\/ajprenal.00290.2002","volume":"284","author":"BC Burckhardt","year":"2003","unstructured":"Burckhardt, B. C. et al. Transport of cimetidine by flounder and human renal organic anion transporter 1. Am. J. Physiol. Renal Physiol. 284, F503\u2013F509 (2003).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1123_CR27","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1124\/dmd.107.017459","volume":"35","author":"A Yamada","year":"2007","unstructured":"Yamada, A. et al. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Drug Metab. Dispos. 35, 2166\u20132176 (2007).","journal-title":"Drug Metab. Dispos."},{"key":"1123_CR28","doi-asserted-by":"crossref","first-page":"107647","DOI":"10.1016\/j.pharmthera.2020.107647","volume":"217","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Wang, H., Fan, Y., Yu, Z. & You, G. Regulation of organic anion transporters: role in physiology, pathophysiology, and drug elimination. Pharmacol. Ther. 217, 107647 (2021).","journal-title":"Pharmacol. Ther."},{"key":"1123_CR29","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1074\/jbc.M508050200","volume":"281","author":"SA Eraly","year":"2006","unstructured":"Eraly, S. A. et al. Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J. Biol. Chem. 281, 5072\u20135083 (2006).","journal-title":"J. Biol. Chem."},{"key":"1123_CR30","doi-asserted-by":"crossref","first-page":"F386","DOI":"10.1152\/ajprenal.00503.2017","volume":"315","author":"Y Fu","year":"2018","unstructured":"Fu, Y. et al. Organic anion transporter OAT3 enhances the glucosuric effect of the SGLT2 inhibitor empagliflozin. Am. J. Physiol. Renal Physiol. 315, F386\u2013F394 (2018).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1123_CR31","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1124\/mol.117.111153","volume":"94","author":"L Zou","year":"2018","unstructured":"Zou, L. et al. Molecular mechanisms for species differences in organic anion transporter 1, OAT1: implications for renal drug toxicity. Mol. Pharmacol. 94, 689\u2013699 (2018).","journal-title":"Mol. Pharmacol."},{"key":"1123_CR32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.V113383","volume":"11","author":"ES Ho","year":"2000","unstructured":"Ho, E. S., Lin, D. C., Mendel, D. B. & Cihlar, T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol. 11, 383\u2013393 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1123_CR33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.13.2.120","volume":"13","author":"RM Mason","year":"1954","unstructured":"Mason, R. M. Studies on the effect of probenecid (benemid) in gout. Ann. Rheum. Dis. 13, 120\u2013130 (1954).","journal-title":"Ann. Rheum. Dis."},{"key":"1123_CR34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00003088-198106020-00004","volume":"6","author":"RF Cunningham","year":"1981","unstructured":"Cunningham, R. F., Israili, Z. H. & Dayton, P. G. Clinical pharmacokinetics of probenecid. Clin. Pharmacokinet. 6, 135\u2013151 (1981).","journal-title":"Clin. Pharmacokinet."},{"key":"1123_CR35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/cpt.2630","volume":"112","author":"JC Granados","year":"2022","unstructured":"Granados, J. C., Bhatnagar, V. & Nigam, S. K. Blockade of organic anion transport in humans after treatment with the drug probenecid leads to major metabolic alterations in plasma and urine. Clin. Pharmacol. Ther. 112, 653\u2013664 (2022).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1123_CR36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-199936020-00004","volume":"36","author":"KC Cundy","year":"1999","unstructured":"Cundy, K. C. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin. Pharmacokinet. 36, 127\u2013143 (1999).","journal-title":"Clin. Pharmacokinet."},{"key":"1123_CR37","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jama.1944.02850510015003","volume":"126","author":"KH Beyer","year":"1944","unstructured":"Beyer, K. H., Flippin, H., Verwey, W. F. & Woodward, R. The effect of para-aminohippuric acid on plasma concentration of penicillin in man. JAMA 126, 1007\u20131009 (1944).","journal-title":"JAMA"},{"key":"1123_CR38","doi-asserted-by":"crossref","first-page":"32285","DOI":"10.1074\/jbc.M501447200","volume":"280","author":"M Hong","year":"2005","unstructured":"Hong, M. et al. Human organic anion transporter hOAT1 forms homooligomers. J. Biol. Chem. 280, 32285\u201332290 (2005).","journal-title":"J. Biol. Chem."},{"key":"1123_CR39","doi-asserted-by":"crossref","first-page":"e35383","DOI":"10.7554\/eLife.35383","volume":"7","author":"T Grant","year":"2018","unstructured":"Grant, T., Rohou, A. & Grigorieff, N. cisTEM, user-friendly software for single-particle image processing.eLife 7, e35383 (2018).","journal-title":"eLife"},{"key":"1123_CR40","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cell.2020.11.043","volume":"184","author":"N Wang","year":"2021","unstructured":"Wang, N. et al. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates. Cell 184, 370\u2013383 e313 (2021).","journal-title":"Cell"},{"key":"1123_CR41","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1021\/acs.chemrev.0c00983","volume":"121","author":"D Drew","year":"2021","unstructured":"Drew, D., North, R. A., Nagarathinam, K. & Tanabe, M. Structures and general transport mechanisms by the major facilitator superfamily (MFS).Chem. Rev. 121, 5289\u20135335 (2021).","journal-title":"Chem. Rev."},{"key":"1123_CR42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34284-8","volume":"13","author":"B Khanppnavar","year":"2022","unstructured":"Khanppnavar, B. et al. Structural basis of organic cation transporter-3 inhibition. Nat. Commun. 13, 6714 (2022).","journal-title":"Nat. Commun."},{"key":"1123_CR43","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1096\/fj.11-180679","volume":"26","author":"S Brast","year":"2012","unstructured":"Brast, S. et al. The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization. FASEB J. 26, 976\u2013986 (2012).","journal-title":"FASEB J."},{"key":"1123_CR44","doi-asserted-by":"crossref","first-page":"37874","DOI":"10.1074\/jbc.M111.289330","volume":"286","author":"T Keller","year":"2011","unstructured":"Keller, T. et al. The large extracellular loop of organic cation transporter 1 influences substrate affinity and is pivotal for oligomerization. J. Biol. Chem. 286, 37874\u201337886 (2011).","journal-title":"J. Biol. Chem."},{"key":"1123_CR45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.sbi.2010.05.008","volume":"20","author":"M Miyano","year":"2010","unstructured":"Miyano, M., Ago, H., Saino, H., Hori, T. & Ida, K. Internally bridging water molecule in transmembrane alpha-helical kink. Curr. Opin. Struct. Biol. 20, 456\u2013463 (2010).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"1123_CR46","doi-asserted-by":"crossref","first-page":"13402","DOI":"10.1074\/jbc.M609849200","volume":"282","author":"AN Rizwan","year":"2007","unstructured":"Rizwan, A. N., Krick, W. & Burckhardt, G. The chloride dependence of the human organic anion transporter 1 (hOAT1) is blunted by mutation of a single amino acid. J. Biol. Chem. 282, 13402\u201313409 (2007).","journal-title":"J. Biol. Chem."},{"key":"1123_CR47","doi-asserted-by":"crossref","first-page":"38071","DOI":"10.1074\/jbc.M608834200","volume":"281","author":"JL Perry","year":"2006","unstructured":"Perry, J. L., Dembla-Rajpal, N., Hall, L. A. & Pritchard, J. B. A three-dimensional model of human organic anion transporter 1: aromatic amino acids required for substrate transport. J. Biol. Chem. 281, 38071\u201338079 (2006).","journal-title":"J. Biol. Chem."},{"key":"1123_CR48","first-page":"97","volume":"98","author":"KH Beyer","year":"1954","unstructured":"Beyer, K. H. Factors basic to the development of useful inhibitors of renal transport mechanisms. Arch. Int. Pharmacodyn. Ther. 98, 97\u2013117 (1954).","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"1123_CR49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/abio.2000.4633","volume":"283","author":"T Cihlar","year":"2000","unstructured":"Cihlar, T. & Ho, E. S. Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1. Anal. Biochem. 283, 49\u201355 (2000).","journal-title":"Anal. Biochem."},{"key":"1123_CR50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12539-015-0263-z","volume":"7","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y. et al. Conformational preferences of \u03c0\u2013\u03c0 stacking between ligand and protein, analysis derived from crystal structure data geometric preference of \u03c0\u2013\u03c0 interaction. Interdiscip. Sci. 7, 211\u2013220 (2015).","journal-title":"Interdiscip. Sci."},{"key":"1123_CR51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejphar.2018.10.028","volume":"842","author":"R Fraser-Spears","year":"2019","unstructured":"Fraser-Spears, R. et al. Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter. Eur. J. Pharmacol. 842, 351\u2013364 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"1123_CR52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrm.2015.25","volume":"17","author":"EM Quistgaard","year":"2016","unstructured":"Quistgaard, E. M., Low, C., Guettou, F. & Nordlund, P. Understanding transport by the major facilitator superfamily (MFS): structures pave the way. Nat. Rev. Mol. Cell Biol. 17, 123\u2013132 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1123_CR53","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1124\/jpet.106.117663","volume":"320","author":"M Hong","year":"2007","unstructured":"Hong, M., Zhou, F., Lee, K. & You, G. The putative transmembrane segment 7 of human organic anion transporter hOAT1 dictates transporter substrate binding and stability. J. Pharmacol. Exp. Ther. 320, 1209\u20131215 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1123_CR54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/jpet.116.232660","volume":"359","author":"HC Liu","year":"2016","unstructured":"Liu, H. C. et al. Molecular properties of drugs interacting with SLC22 transporters OAT1, OAT3, OCT1, and OCT2: a machine-learning approach. J. Pharmacol. Exp. Ther. 359, 215\u2013229 (2016).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1123_CR55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01213011-200504000-00003","volume":"15","author":"T Fujita","year":"2005","unstructured":"Fujita, T. et al. Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenet. Genomics 15, 201\u2013209 (2005).","journal-title":"Pharmacogenet. Genomics"},{"key":"1123_CR56","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/jpet.105.084301","volume":"314","author":"K Bleasby","year":"2005","unstructured":"Bleasby, K., Hall, L. A., Perry, J. L., Mohrenweiser, H. W. & Pritchard, J. B. Functional consequences of single nucleotidepolymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J. Pharmacol. Exp. Ther. 314, 923\u2013931 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1123_CR57","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.3390\/ijms21186627","volume":"21","author":"Z Zazuli","year":"2020","unstructured":"Zazuli, Z. et al. The impact of genetic polymorphisms in organic cation transporters on renal drug disposition.Int. J. Mol. Sci. 21, 6627 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1123_CR58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/clpt.2009.92","volume":"86","author":"MV Tzvetkov","year":"2009","unstructured":"Tzvetkov, M. V. et al. The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin. Clin. Pharmacol. Ther. 86, 299\u2013306 (2009).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1123_CR59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1289\/ehp.1204951","volume":"121","author":"K Engstrom","year":"2013","unstructured":"Engstrom, K. et al. Polymorphisms in genes encoding potential mercury transporters and urine mercury concentrations in populations exposed to mercury vapor from gold mining. Environ. Health Perspect. 121, 85\u201391 (2013).","journal-title":"Environ. Health Perspect."},{"key":"1123_CR60","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1681\/ASN.V12102012","volume":"12","author":"NA Wolff","year":"2001","unstructured":"Wolff, N. A. et al. Cationic amino acids involved in dicarboxylate binding of the flounder renal organic anion transporter. J. Am. Soc. Nephrol. 12, 2012\u20132018 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1123_CR61","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/bi002841o","volume":"40","author":"B Feng","year":"2001","unstructured":"Feng, B., Dresser, M. J., Shu, Y., Johns, S. J. & Giacomini, K. M. Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3. Biochemistry 40, 5511\u20135520 (2001).","journal-title":"Biochemistry"},{"key":"1123_CR62","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1124\/jpet.108.146225","volume":"329","author":"G Minuesa","year":"2009","unstructured":"Minuesa, G. et al. Transport of lamivudine[(-)-beta-l-2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine] and high-affinity interaction ofnucleoside reverse transcriptase inhibitors with human organic cationtransporters 1, 2, and 3.J. Pharmacol. Exp. Ther. 329, 252\u2013261 (2009).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1123_CR63","first-page":"10","volume":"295","author":"AS Mulato","year":"2000","unstructured":"Mulato, A. S., Ho, E. S. & Cihlar, T. Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1. J. Pharmacol. Exp. Ther. 295, 10\u201315 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1123_CR64","volume":"11","author":"T Taniguchi","year":"2021","unstructured":"Taniguchi, T. et al. Hypouricemic agents reduce indoxyl sulfate excretion by inhibiting the renal transporters OAT1\/3 and ABCG2. Sci. Rep. 11, 7232 (2021).","journal-title":"Sci. Rep."},{"key":"1123_CR65","doi-asserted-by":"crossref","first-page":"F1026","DOI":"10.1152\/ajprenal.00169.2011","volume":"301","author":"M Kaufhold","year":"2011","unstructured":"Kaufhold, M. et al. Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3. Am. J. Physiol. Renal Physiol. 301, F1026\u2013F1034 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1123_CR66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12013-011-9191-7","volume":"61","author":"IF Tsigelny","year":"2011","unstructured":"Tsigelny, I. F. et al. Conformational changes of the multispecific transporter organic anion transporter 1 (OAT1\/SLC22A6) suggests a molecular mechanism for initial stages of drug and metabolite transport. Cell Biochem. Biophys. 61, 251\u2013259 (2011).","journal-title":"Cell Biochem. Biophys."},{"key":"1123_CR67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-10755-2","volume":"12","author":"A Janaszkiewicz","year":"2022","unstructured":"Janaszkiewicz, A. et al. Insights into the structure and function of the human organic anion transporter 1 in lipid bilayer membranes. Sci. Rep. 12, 7057 (2022).","journal-title":"Sci. Rep."},{"key":"1123_CR68","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1440-1797.2010.01368.x","volume":"16","author":"HJ Shin","year":"2011","unstructured":"Shin, H. J. et al. Interactions of urate transporter URAT1 in human kidney with uricosuric drugs. Nephrology (Carlton) 16, 156\u2013162 (2011).","journal-title":"Nephrology (Carlton)"},{"key":"1123_CR69","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1124\/jpet.301.3.797","volume":"301","author":"A Enomoto","year":"2002","unstructured":"Enomoto, A. et al. Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J. Pharmacol. Exp. Ther. 301, 797\u2013802 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1123_CR70","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/art.40159","volume":"69","author":"N Dalbeth","year":"2017","unstructured":"Dalbeth, N. et al. Lesinurad, a selective uric acid reabsorption inhibitor, in combination with febuxostat in patients with tophaceous gout: findings of a phase III clinical trial. Arthritis Rheumatol. 69, 1903\u20131913 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"1123_CR71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/jpet.119.259341","volume":"371","author":"T Taniguchi","year":"2019","unstructured":"Taniguchi, T. et al. Pharmacological evaluation of dotinurad, a selective urate reabsorption inhibitor. J. Pharmacol. Exp. Ther. 371, 162\u2013170 (2019).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1123_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.62.1.1-34.1998","volume":"62","author":"SS Pao","year":"1998","unstructured":"Pao, S. S., Paulsen, I. T. & Saier, M. H. Jr. Major facilitator superfamily. Microbiol. Mol. Biol. Rev. 62, 1\u201334 (1998).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1123_CR73","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-biophys-060414-033901","volume":"44","author":"N Yan","year":"2015","unstructured":"Yan, N. Structural biology of the major facilitator superfamily transporters. Annu. Rev. Biophys. 44, 257\u2013283 (2015).","journal-title":"Annu. Rev. Biophys."},{"key":"1123_CR74","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.aba9202","volume":"368","author":"F Li","year":"2020","unstructured":"Li, F. et al. Ion transport and regulation in a synaptic vesicle glutamate transporter. Science 368, 893\u2013897 (2020).","journal-title":"Science"},{"key":"1123_CR75","doi-asserted-by":"crossref","first-page":"eabh3355","DOI":"10.1126\/sciadv.abh3355","volume":"7","author":"JL Parker","year":"2021","unstructured":"Parker, J. L. et al. Cryo-EM structure of PepT2 reveals structural basis for proton-coupled peptide and prodrug transport in mammals.Sci. Adv. 7, eabh3355 (2021).","journal-title":"Sci. Adv."},{"key":"1123_CR76","doi-asserted-by":"crossref","first-page":"eabk3259","DOI":"10.1126\/sciadv.abk3259","volume":"7","author":"M Killer","year":"2021","unstructured":"Killer, M., Wald, J., Pieprzyk, J., Marlovits, T. C. & Low, C. Structural snapshots of human PepT1 and PepT2 reveal mechanistic insights into substrate and drug transport across epithelial membranes. Sci. Adv. 7, eabk3259 (2021).","journal-title":"Sci. Adv."},{"key":"1123_CR77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","volume":"151","author":"C Suloway","year":"2005","unstructured":"Suloway, C. et al. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 151, 41\u201360 (2005).","journal-title":"J. Struct. Biol."},{"key":"1123_CR78","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"1123_CR79","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"1123_CR80","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153\u20131160 (2019).","journal-title":"Nat. Methods"},{"key":"1123_CR81","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1042\/BCJ20210708","volume":"478","author":"D Kimanius","year":"2021","unstructured":"Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169\u20134185 (2021).","journal-title":"Biochem. J."},{"key":"1123_CR82","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. CryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"1123_CR83","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"1123_CR84","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"1123_CR85","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D"},{"key":"1123_CR86","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."}],"container-title":["Nature Structural &amp; Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41594-023-01123-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41594-023-01123-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41594-023-01123-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T14:20:26Z","timestamp":1699885226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41594-023-01123-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":86,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1123"],"URL":"https:\/\/doi.org\/10.1038\/s41594-023-01123-3","relation":{},"ISSN":["1545-9993","1545-9985"],"issn-type":[{"value":"1545-9993","type":"print"},{"value":"1545-9985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"1 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}